Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here: https://rb.gy/09bxx

Press releases

February 21, 2024 | REGULATORY

Immunovia Publishes Full Year Report for 2023

Read press release
November 21, 2023 | REGULATORY

Bulletin from the extraordinary general meeting in Immunovia AB

Read press release
November 9, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-September 2023

Read press release
October 27, 2023 | REGULATORY

CONVENING NOTICE – EXTRAORDINARY GENERAL MEETING IN IMMUNOVIA AB (PUBL)

Read press release
October 3, 2023 | REGULATORY

Nomination Committee appointed for Immunovia AB (Publ)

Read press release
August 30, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-June 2023

Read press release
July 11, 2023 | REGULATORY

Immunovia to Significantly Restructure to Focus Resources on its Next-Generation Blood Test for Pancreatic Cancer Detection

Read press release
May 31, 2023 | REGULATORY

Change in number of shares and votes in Immunovia AB (publ)

Read press release
May 26, 2023 | REGULATORY

Bulletin from the Annual General Meeting in Immunovia AB

Read press release
May 23, 2023 | REGULATORY

Immunovia Publishes Interim Report for January-March 2023

Read press release
May 22, 2023 | REGULATORY

Changes to the Nomination Committee’s proposal to the Annual General Meeting 2023 in Immunovia AB (publ)

Read press release
May 6, 2023 | REGULATORY

The board member Philipp von Hugo resigns from Immunovia’s board at his own request

Read press release
1 2 3 … 15
Home Press releases